Exhibit 1.1
PLACEMENT AGENCY
AGREEMENT
December 21, 2005
Roth Capital Partners, LLC
24 Corporate Plaza
Newport Beach, CA 92660
Ladies and Gentlemen:
Introductory
. Subject to the terms and
conditions herein, CollaGenex Pharmaceuticals, Inc., a Delaware
corporation (the “Company”), proposes to issue and sell
to certain investors (collectively, the “Investors”) up
to an aggregate of 2,900,000 shares (the “Offering”) of
common stock, $.01 par value per share, of the Company (the
“Common Stock”). The shares of Common Stock to be
issued to the Investors in the Offering are hereinafter referred to
as the “Shares.” The Company desires to engage
Roth Capital Partners, LLC as its exclusive lead placement agent
(the “Placement Agent”) in connection with such sale
and issuance.
The Company hereby confirms its
agreement with the Placement Agent as follows:
Section 1.
Agreement to Act as Placement Agent .
(a)
On the basis of the representations, warranties and agreements of
the Company herein contained, and subject to all the terms and
conditions of this Placement Agency Agreement (this
“Agreement”), the Placement Agent shall be the
exclusive placement agent in connection with the issuance and sale
by the Company of the Shares to the Investors in the
Offering. The Placement Agent shall act on a best efforts
basis and does not guarantee that it will be able to sell the
Shares in the Offering. As compensation for services
rendered, and provided that any of the Shares are sold to Investors
in the Offering, on each Closing Date (as defined in Section 3
below) of the Offering, the Company shall pay to the Placement
Agent a cash fee equal to 4.5% of the gross proceeds received by
the Company from the sale of the Shares in the Offering on such
Closing Date; provided that the Company may, upon each Closing Date
or on the final Closing Date of the Offering and in its discretion,
pay up to 1.5% of the gross proceeds received by the Company from
the sale of the Shares in the Offering on such Closing Date to
SunTrust Robinson Humphrey Capital Markets for financial advisory
services rendered to the Company, which shall be such bank’s
sole and exclusive fee with respect to the Offering. The
purchase price for each Share is $10.00. This Agreement shall
not give rise to any commitment by the Placement Agent to purchase
any of the Shares.
(b)
The term of the Placement Agent’s exclusive engagement with
respect to the Offering will be 90 days; however, either party may
terminate this Agreement at any time upon 10 days written notice to
the other parties. Upon termination, the Placement Agent will
be entitled to collect the fee, if any, described in Section 1(a)
above and earned through the date of termination and to be
reimbursed by the Company for those expenses described in Section 7
below incurred through the date of termination.
Notwithstanding the foregoing, if during the 180 day period
beginning on the date hereof, the Company issues and sells any
securities of the Company to any of the individuals or entities
listed on Exhibit A attached hereto and this Agreement has
not been terminated (i) by the Company due to a material breach by
the Placement Agent under this Agreement, (ii) by the Company due
to the Placement Agent’s bad faith, gross negligence,
recklessness or willful misconduct, or (iii) by the Placement Agent
without cause, the Company agrees to pay to Roth Capital upon the
closing of such transaction or transactions a cash fee equal to
4.5% of the gross proceeds received by the Company in such
transaction or transactions.
Nothing in this Agreement shall be construed to
limit the ability of the Placement Agent or its affiliates to
pursue, investigate, analyze, invest in, or engage in investment
banking, financial advisory or any other business relationship with
entities or persons other than the Company.
Section 2.
Representations, Warranties and Covenants of the Company
.
The Company hereby represents,
warrants and covenants to the Placement Agent as of the date
hereof, and as of each Closing Date, as follows:
(a)
Securities Law Filings . The Company has filed with
the Securities and Exchange Commission (the
“Commission”) a registration statement on Form S-3
(Registration file No. 333-128334), which became effective on
October 11, 2005, for the registration under the Securities Act of
1933, as amended (the “Act”) of the Shares. On
the date of the filing of such registration statement, the Company
met the requirements for use of Form S-3 under the Act. Such
registration statement complies in all material respects with the
requirements of the Act. The Company will file with the
Commission pursuant to Rule 424(b) under the Act a supplement to
the form of prospectus included in such registration statement
relating to a placement of the Shares and the plan of distribution
thereof and the Company has advised the Placement Agent of all
further information (financial and other) with respect to the
Company to be set forth therein. Such registration statement,
including the exhibits thereto, as amended at the date of this
Agreement, is hereinafter called the “Registration
Statement”; such prospectus in the form in which it appears
in the Registration Statement is hereinafter called the “Base
Prospectus”; and each supplemented form of prospectus, in the
form in which it will be filed with the Commission pursuant to Rule
424(b) is hereinafter called a “Prospectus
Supplement.” Any reference herein to the Registration
Statement, the Base Prospectus or a Prospectus Supplement shall be
deemed to refer to and include the documents, if any, which may be
incorporated by reference therein (the “Incorporated
Documents”) pursuant to Form S-3 which were filed under
the Securities Exchange Act of 1934, as amended (the
“Exchange Act”), on or before the date of this
Agreement, or the issue date of the Base Prospectus or any
Prospectus Supplement, as the case may be; and any reference herein
to the terms “amend,” “amendment” or
“supplement” with respect to the Registration
Statement, the Base Prospectus or a Prospectus Supplement shall be
deemed to refer to and include the filing of any document under the
Exchange Act after the date of this Agreement, or the issue date of
the Base Prospectus or any Prospectus Supplement, as the case may
be, deemed to be incorporated therein by reference. All
references in this Agreement to financial statements and schedules
and other information which is “contained,”
“included” or “stated” in the Registration
Statement or any Prospectus Supplement (and all other references of
like import) shall be deemed to mean and include all such financial
statements and schedules and other information which is or is
deemed to be incorporated by reference in the Registration
Statement or such Prospectus Supplement, as the case may
be.
(b)
No Stop Order . No stop order suspending the
effectiveness of the Registration Statement or the use of the Base
Prospectus or the Prospectus Supplement has been issued, and no
proceeding for any such purpose is pending or has been initiated
or, to the Company’s knowledge, is threatened by the
Commission.
(c)
Compliance with Applicable Regulations . The
Registration Statement contains all exhibits and schedules as
required by the Act. Each of the Registration Statement and
any post-effective amendment thereto, at the time it became
effective, complied in all material respects with the requirements
of the Act and the applicable rules and regulations of the
Commission thereunder and did not contain any untrue statement of a
material fact or omit to state a material fact required to be
stated therein or necessary to make the statements therein not
misleading. Each of the Base Prospectus and each Prospectus
Supplement, as of its respective date, complied (or in the case of
any Prospectus Supplement will comply) in all material respects
with the Act and the applicable rules and regulations of
the
2
Commission thereunder. Each of
the Base Prospectus and the Prospectus Supplement, as amended or
supplemented, did not contain as of the effective date thereof, and
will not as of each Closing Date contain, any untrue statement of a
material fact or omit to state a material fact necessary in order
to make the statements therein, in light of the circumstances under
which they were made, not misleading. The Incorporated
Documents, if any, when they were filed with the Commission,
conformed in all material respects to the requirements of the
Exchange Act and the applicable rules and regulations of the
Commission thereunder, and none of such documents, when they were
filed with the Commission, contained any untrue statement of a
material fact or omitted to state a material fact necessary to make
the statements therein not misleading; and any further documents so
filed and incorporated by reference in the Base Prospectus or
Prospectus Supplement, when such documents are filed with the
Commission, will conform in all material respects to the
requirements of the Exchange Act and the applicable rules and
regulations of the Commission thereunder, as applicable, and will
not contain any untrue statement of a material fact or omit to
state a material fact necessary in order to make the statements
therein, in light of the circumstances under which they were made,
not misleading. Notwithstanding the foregoing, the Company
makes no representations or warranties as to the information
contained in or omitted from any Prospectus Supplement or any
amendment thereof or supplement thereto in reliance upon and in
conformity with information furnished in writing to the Company by
or on behalf of the Placement Agent specifically for use in the
Registration Statement or such Prospectus Supplement. No
post-effective amendment to the Registration Statement reflecting
any facts or events arising after the effective date thereof which
represent, individually or in the aggregate, a fundamental change
in the information set forth therein is required to be filed with
the Commission.
(d)
Reports and Documents, etc . There are no documents
required to be filed with the Commission in connection with the
transaction contemplated hereby that (i) have not been filed
as required pursuant to the Act or (ii) will not be filed
within the requisite time period. There are no contracts or
other documents required to be described in any Prospectus
Supplement, or to be filed as exhibits or schedules to the
Registration Statement, which have not been or will not be
described or filed as required.
(e)
Offering Materials Furnished to the Placement Agent .
The Company has delivered, or will as promptly as practicable
deliver, to the Placement Agent complete conformed copies of the
Registration Statement and of each consent and certificate of
experts filed as a part thereof, and conformed copies of the
Registration Statement (without exhibits) and the Base Prospectus
and each Prospectus Supplement, as amended or supplemented, in such
quantities and at such places as the Placement Agent reasonably
requests.
(f)
Distribution of Offering Material . The Company has
not distributed and will not distribute, prior to each Closing
Date, any offering material in connection with the offering and
sale of the Shares other than the Base Prospectus and a Prospectus
Supplement or the Registration Statement and copies of the
documents incorporated by reference therein. For the
avoidance of doubt, any other material prepared and distributed
solely by the Placement Agent is not deemed to be distributed by
the Company for purposes of this paragraph (f).
(g)
The Placement Agency Agreement . This Agreement has
been duly authorized, executed and delivered by, and is a valid and
binding agreement of, the Company, enforceable against the Company
in accordance with its terms, except as rights to indemnification
and contribution hereunder may be limited by applicable law and
except as the enforcement hereof may be limited by bankruptcy,
insolvency, reorganization, moratorium or other similar laws
relating to or affecting the rights and remedies of creditors or by
general equitable principles.
3
(h)
Authorization of the Shares . The Shares have been
duly authorized for issuance and sale. The Shares, when
issued and delivered by the Company to the Investors against
payment therefor pursuant to this Agreement or any subscription
agreement between the Company and such Investors, will be validly
issued, fully paid and nonassessable.
(i)
No Applicable Registration or Other Similar Rights .
There are no persons with registration, preemptive or other similar
rights to acquire any securities being offered in the Offering
contemplated by this Agreement or to have any securities (whether
equity, debt or any combination thereof) registered or qualified
for sale under the Registration Statement or a Prospectus
Supplement or included in the Offering contemplated by this
Agreement, except, in each case, for such rights as have been duly
waived or satisfied.
(j)
No Material Adverse Change . Subsequent to the
respective dates as of which information is given in the Base
Prospectus and in any Prospectus Supplement: (i) there has
been no material adverse change or effect in the assets,
properties, financial condition, or in the results of operations of
the Company and the Subsidiaries (as defined in Section 2(m) below)
taken as a whole (any such change or effect, where the context so
requires, is called a “Material Adverse Change” or a
“Material Adverse Effect”); (ii) the Company and the
Subsidiaries have not incurred any material liability or
obligation, indirect, direct or contingent, not in the ordinary
course of business nor entered into any material transaction or
agreement not in the ordinary course of business; and (iii) there
has been no dividend or distribution of any kind declared, paid or
made by the Company on any class of capital stock or repurchase or
redemption by the Company of any class of capital stock except as
disclosed in the Incorporated Documents.
(k)
Independent Accountants . To the Company’s
knowledge, KPMG LLP, which have expressed their opinion with
respect to the financial statements (which term as used in this
Agreement includes the related notes and schedules thereto) and
supporting schedules filed with the Commission as a part of the
Registration Statement and incorporated by reference in the Base
Prospectus or any Prospectus Supplement, are independent registered
public accountants as required by the Act and the Exchange
Act.
(l)
Preparation of the Financial Statements . The
financial statements (including all notes and schedules thereto)
filed with the Commission as a part of the Registration Statement
or included or incorporated by reference in the Base Prospectus or
a Prospectus Supplement present fairly the financial position of
the Company and its consolidated subsidiaries as of and at the
dates indicated and the results of their operations and cash flows
for the periods specified therein. Such financial statements
and supporting schedules, if any, have been prepared in conformity
with generally accepted accounting principles as applied in the
United States (“GAAP”), as applicable, applied on a
consistent basis throughout the periods involved (provided that
non-year-end financial statements are subject to normal recurring
year-end audit adjustments and do not contain all footnotes
required by GAAP). No other financial statements or
supporting schedules or exhibits are required by the Act or the
rules and regulations of the Commission thereunder to be included
in the Registration Statement, the Base Prospectus or the
Prospectus Supplement.
(m)
Incorporation and Good Standing . Each of the Company
and its subsidiaries set forth in Exhibit B hereto (the
“Subsidiaries”) has been duly organized and is validly
existing and, as applicable, is a corporation in good standing
under the laws of its jurisdiction of incorporation with full
corporate power and authority to own its properties and other
assets and conduct its business as described in the Prospectus
Supplement, and is duly qualified or licensed to do business as a
foreign corporation and, as applicable, is in good standing under
the laws of each jurisdiction which requires such qualification or
license, except where the failure to be so qualified or in good
standing would not have a Material Adverse Effect.
4
(n)
Capitalization and Other Capital Stock Matters . The
authorized, issued and outstanding capital stock of the Company is
as set forth in the Registration Statement and in each Prospectus
Supplement (other than for issuances after the dates thereof, if
any, pursuant to employee benefit plans described in any Prospectus
Supplement or upon exercise of outstanding options or warrants
described in any Prospectus Supplement). The Shares conform
in all material respects to the description thereof contained in
the Registration Statement as supplemented by the Prospectus
Supplement. The outstanding capital stock of the Company, and
the outstanding options, warrants, or convertible securities of the
Company, are as described in the Registration Statement as
supplemented by the Prospectus Supplement, as of the date such
information is presented therein. As of the effective date of
the Registration Statement, except as described in the Incorporated
Documents, there were 14,475,047 shares of common stock
outstanding. Since the effective date of the Registration
Statement, the Company has not issued any securities other than
Common Stock of the Company pursuant to the exercise of previously
outstanding options in connection with the Company’s option
plans (the “Plans”) and options granted pursuant to the
Plans in the ordinary course of business consistent with past
practice, in each case as disclosed in the Registration Statement
as supplemented by Prospectus Supplement. All the issued and
outstanding shares of the capital stock of the Company and the
Subsidiaries have been duly authorized and validly issued, are
fully paid and nonassessable and have been issued in compliance, in
all material respects, with federal and state securities laws, as
applicable. Except as set forth in the Registration Statement
as supplemented by the Prospectus Supplement, all of the
outstanding shares of capital stock of the Subsidiaries are owned,
directly or indirectly, by the Company. To the knowledge of
the Company, since January 1, 2001, none of the outstanding shares
of capital stock of the Company or any Subsidiary were issued in
violation of any preemptive rights, rights of first refusal or
other similar rights to subscribe for or purchase securities.
There are no authorized or outstanding options, warrants,
preemptive rights, rights of first refusal or other rights to
purchase, or equity or debt securities convertible into or
exchangeable or exercisable for, any capital stock of the Company
or any Subsidiary other than those described in the Registration
Statement as supplemented by the Prospectus Supplement. The
descriptions of the Company’s stock option plans, bonus and
other compensation arrangements, and the options, warrants or other
rights granted thereunder, set forth in the Registration Statement
as supplemented by the Prospectus Supplement accurately and fairly
present in all material respects the information required to be
described with respect to such plans, arrangements, options and
rights. Except as set forth in the Registration Statement as
supplemented by the Prospectus Supplement, the Company does not
have any subsidiaries or own directly or indirectly any of the
capital stock or other equity or long-term debt securities or have
any equity interest in any other person.
(o)
Stock Exchange Listing . The Common Stock (including
the Shares) is registered under the Exchange Act and is, or as of
each Closing Date will be, listed on the Nasdaq National Market
(the “NNM”). The Company has taken no action
designed to, or likely to have the effect of, terminating the
registration of the Common Stock under the Exchange Act or
delisting or suspending from trading the Common Stock on the NNM,
nor has the Company received any written notice from the Commission
or the NNM that the Commission or the NNM is contemplating
terminating or suspending such registration or listing.
(p)
No Consents, Approvals or Authorizations Required . No
consent, approval, authorization, filing with or order of any court
or governmental agency or regulatory body or vote of the
Company’s shareholders is required in connection with the
performance by the Company of its obligations under this Agreement
or the offering or sale of the Shares hereunder, except such as
have been obtained or made or are contemplated by Section 2(a) or
Section 5 to be obtained or made and any necessary qualification
under the securities or blue sky laws of the various jurisdictions
in which the Shares are being offered, under the terms of this
Agreement, under the rules and regulations of the National
Association of Securities Dealers, Inc. (the “NASD”),
or under the rules and regulations of the NNM.
5
(q)
Non-Contravention of Existing Instruments and Agreements
. Neither the issue and sale of the Shares nor the
performance by the Company of its obligations under this Agreement
nor the fulfillment of the terms hereof will conflict with, result
in a breach or violation of, or the loss of any benefit under, or
give rise to a right of acceleration or any other right, or the
imposition of any lien, charge or encumbrance upon any property or
assets of the Company or any Subsidiary pursuant to: (i) the
charter or by-laws of the Company or any Subsidiary; (ii) the terms
of any indenture, contract, lease, mortgage, deed of trust, note
agreement, loan agreement or other agreement, obligation,
condition, covenant or instrument to which the Company or any
Subsidiary is a party or is bound or to which any of its property
is subject and which conflict, breach, violation, loss of benefit,
acceleration, imposition of lien, charge or encumbrance is
reasonably likely to have a Material Adverse Effect; or (iii) any
statute, law, rule, regulation, judgment, order or decree
applicable to the Company or any Subsidiary, as the case may be, of
any court, regulatory body, administrative agency, governmental
body, arbitrator or other authority having jurisdiction over the
Company or such Subsidiary, as the case may be, or any of its
property, the result of which is reasonably likely to have a
Material Adverse Effect.
(r)
No Defaults or Violations . None of the Company or any
Subsidiary is in violation or default of: (i) any provision
of its charter or by-laws; (ii) the terms of any indenture,
contract, lease, mortgage, deed of trust, note agreement, loan
agreement or other agreement, obligation, condition, covenant or
instrument to which it is a party or by which it is bound or to
which any of its property is subject; or (iii) any foreign,
federal, state or local statute, law or rule applicable to the
Company or any Subsidiary, as the case may be, or any regulation,
judgment, order or decree of any court, governmental body, or
agency having jurisdiction over the Company or such Subsidiary, as
the case may be, or any of its property, as applicable, except in
case of clause (ii) and (iii) any such violation or default which
would not, singly or in the aggregate, reasonably be expected to
result in a Material Adverse Change not specifically disclosed in
the Registration Statement as supplemented by the Prospectus
Supplement.
(s)
No Actions, Suits or Proceedings . No action, suit or
proceeding by or before any foreign, federal, state or local court
or governmental agency, authority or body or any arbitrator
involving the Company or any Subsidiary, as the case may be, or any
of its property is pending or, to the best knowledge of the
Company, threatened that if adversely determined: (i) could
reasonably be expected to have a Material Adverse Effect on the
performance of this Agreement or the consummation of any of the
transactions contemplated hereby; or (ii) except as disclosed in
the Registration Statement as supplemented by the Prospectus
Supplement, could reasonably be expected to result in a Material
Adverse Effect.
(t)
All Necessary Permits, Etc . To the best of the
Company’s knowledge, each of the Company and its Subsidiaries
possesses such valid and current certificates, authorizations and
permits issued by the appropriate foreign, federal, state or local
regulatory agencies or bodies necessary to conduct its business as
currently conducted, except to the extent that the failure to
obtain such certificates, authorizations or permits would not have
a Material Adverse Effect, and neither the Company nor any
Subsidiary has received any notice of proceedings relating to the
revocation or modification of, or non-compliance with, any such
certificate, authorization or permit which, singly or in the
aggregate, if the subject of an unfavorable decision, ruling or
finding, could reasonably be expected to result in a Material
Adverse Change.
(u)
Title to Properties . Neither the Company nor any
Subsidiary owns any real property. Each of the Company and
its Subsidiaries has good and marketable title to all personal
property and assets reflected as owned by it in the financial
statements referred to in 2(l) above (or elsewhere in the
Registration Statement as supplemented by the Prospectus
Supplement) and which are material to the business of the Company
or such Subsidiary, in each case free and clear of any security
interests, mortgages, liens, encumbrances, claims and other
defects, except such as would not reasonably be
6
expected to result in a Material Adverse
Effect. The real property, improvements, equipment and
personal property held under lease by each of the Company and its
Subsidiaries are held under valid and enforceable leases, with such
exceptions as are not material, and do not materially interfere
with the use made or proposed to be made of such real property,
improvements, equipment or personal property. The Company and
its Subsidiaries own or have valid rights to use the
intellectual property assets used in their business, necessary to
conduct the business described in the Registration Statement as
supplemented by the Prospectus Supplement, and no material right is
expected to expire, terminate or be disposed of in the foreseeable
future, except as disclosed therein. Except as described in
the Registration Statement as supplemented by the Prospectus
Supplement, the Company has not received any written notice of, and
neither the Company nor any Subsidiary has knowledge of, any
infringement of or conflict with the rights of others, except where
the loss of any such right would not be reasonably likely to have a
Material Adverse Effect.
(v)
Tax Law Compliance . Each of the Company and its
Subsidiaries has filed all necessary foreign, federal, state and
local income and franchise Tax returns, except to the extent that
the failure to file such Tax returns would not have a Material
Adverse Effect, and have paid all Taxes required to be paid by any
of them and, if due and payable, any related or similar assessment,
fine or penalty levied against any of them. Adequate charges,
accruals and reserves have been made in the applicable financial
statements referred to in Section 2(l) above in respect of all
federal, state and foreign income and franchise taxes for all
periods as to which the Tax liability of the Company or any
Subsidiary has not been finally determined. Neither the
Company nor any Subsidiary is aware of any Tax deficiency that has
been or might reasonably be asserted or threatened against it that
could reasonably be expected to result in a Material Adverse
Change. For purposes of this Agreement, the terms
“Tax” and “Taxes” mean all federal, state,
local and foreign taxes, and any other assessments of a similar
nature (whether imposed directly or through withholding),
including, without limitation, any interest, additions to tax, or
penalties applicable thereto. All such Tax returns are true,
complete and correct in all material respects.
(w)
No Transfer Taxes or Other Fees . There are no
transfer Taxes or other similar fees or charges under United States
law or the laws of any state or any political subdivision thereof,
required to be paid in connection with the execution and delivery
of this Agreement or the issuance and sale by the Company of the
Shares.
(x)
Accounting Controls . Each of the Company and its
Subsidiaries (i) makes and keeps accurate books and records, and
(ii) maintains a system of accounting controls sufficient to
provide reasonable assurances that: (A) transactions are
executed in accordance with management’s general or specific
authorization; (B) transactions are recorded as necessary to permit
preparation of financial statements in conformity with GAAP, the
Act and the Exchange Act and the rules and regulations of the
Commission thereunder, and to maintain accountability for assets;
(C) access to assets is permitted only in accordance with
management’s general or specific authorization; and (D)
recorded assets are compared with existing assets at reasonable
intervals and appropriate action is taken with respect to any
differences.
(y)
Company not an “Investment Company.”
Neither the Company nor any Subsidiary is, or immediately after
receipt of payment for the Shares will be, an “investment
company” or an entity “controlled” by an
“investment company” within the meaning of the
Investment Company Act of 1940, as amended. Each of the
Company and its Subsidiaries will conduct its business in a manner
so that it will not become subject to the Investment Company
Act.
(z)
Insurance . Each of the Company and its Subsidiaries
is insured by recognized, financially sound and reputable
institutions with policies in such amounts and with such
deductibles and covering such risks as are prudent and customary in
the business in which it is engaged, including directors and
officers liability. Neither the Company nor any Subsidiary
has any reason to believe that it
7
will not be able: (i) to renew its
existing insurance coverage as and when such policies expire; or
(ii) to obtain comparable coverage from similar institutions as may
be necessary or appropriate to conduct its business as now
conducted. Neither the Company nor any Subsidiary has been
denied any insurance coverage which it has sought or for which it
has applied, such as would have a Material Adverse
Effect.
(aa)
Labor Matters . No material labor disturbance by the
employees of the Company or any Subsidiary exists or, to the
knowledge of the Company or any Subsidiary, is threatened or
imminent, and neither the Company nor any Subsidiary is aware of
any existing, threatened or imminent labor disturbance by the
employees of any of its principal suppliers, manufacturers,
contractors or customers that could reasonably be expected to
result in a Material Adverse Effect.
(bb)
No Price Stabilization or Manipulation . The Company
has not taken and will not take, directly or indirectly, any action
designed to or that could reasonably be expected to cause or result
in stabilization or manipulation of the price of the Common Stock
to facilitate the sale or resale of the Shares.
(cc)
Related Party Transactions . There are no business
relationships or related-party transactions involving the Company
or any Subsidiary required by the Act to be described in the
Registration Statement as supplemented by the Prospectus
Supplement, which have not been described, or incorporated by
reference, therein as required.
(dd)
Exchange Act Reports Filed . The Company has timely
filed all reports required of it to be filed pursuant to the
Exchange Act and has filed all such reports in the manner
prescribed thereby.
(ee)
Exhibits . Each agreement described in or filed as an
exhibit to the Registration Statement, the Base Prospectus and/or
any Prospectus Supplement, including all documents incorporated by
reference therein, is in full force and effect and is valid and
enforceable by the Company or a Subsidiary, as the case may be, in
accordance with its terms, except as the enforceability thereof may
be limited by applicable bankruptcy, insolvency or similar laws
affecting creditors’ rights generally. Neither the
Company nor any Subsidiary, as the case may be, nor, to the
knowledge of the Company or any such Subsidiary, any other party,
is in default in the observance or performance of any term or
obligation to be performed by it under any such agreement, and no
event has occurred that with notice or lapse of time or both would
constitute such a default, in any such case where such default or
event would have a Material Adverse Effect.
(ff)
Blue Sky; NASD Matters. With respect to the
compensation to be paid to the Placement Agent under this
Agreement, the Company has made the initial filings required by
Rule 2710 of the NASD with resp